Document

NDTS (PDF Version)

ICR 201210-1117-001 · OMB 1117-0052 · Object 35282701.

Document Viewer [docx]

Status: Original and derived artifacts are available for this document.

Download: docx | pdf | html

Primary: docxSource: application/vnd.openxmlformats-officedocument.wordprocessingml.document
Loading document viewer…
Document Metadata
File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleNDTS (PDF Version)
AuthorWiegand, Francine H.
Last Modified ByWriter
File Modified2012-09-17
File Created2026-07-15
Conversion Statecomplete
Extracted Text
National Drug Threat Survey 2013

U.S. Department of Justice
Drug Enforcement Administration
Attn: Fran Wiegand, Project Manager (NDTS)
8701 Morrissette Drive
Springfield, VA 22152
Phone: (202) 353-1112
Fax: (202) 307-8955





Please provide the following information:

Law Enforcement Agency:

Title (of person completing survey): 

First Name: 	MI: 	Last Name:

Address: 	State: 	Zip:

Telephone: 	Fax:

E-mail Address:

























OMB No.: XXXXXXXXX (Expiration date XXXXXXX)	Rev: XXXXXXXXX	DEA Form XXXX

Greatest Drug Threat and Drug-Related Crime
1. For your jurisdiction, please indicate the drug that poses the greatest threat, the drug that most contributes to violent crime and the drug that most contributes to property crime. (Choose only ONE drug on each list.)

	Greatest Drug Threat	Violent Crime	Property Crime
(Choose only ONE)	(Choose only ONE)	(Choose only ONE)

















1a. Over the past year, has your agency experienced a significant change in a drug trafficking attribute (availability, demand, distribution, production, transportation) for any of the listed drugs? Please explain by indicating next to the appropriate drug the attribute and whether the change is an increase or decrease.


Drug
Attribute
Change
Powder cocaine


Crack cocaine


Heroin


Methamphetamine


Marijuana


Controlled prescription drugs


Bath salts


Synthetic cannabinoids


Other (specify)



Drug Availability
2. Indicate the level of availability of the following drugs in your jurisdiction using the following definitions:
	Low availability – drug is difficult to obtain most of the time
	Moderate availability – drug is easily obtained most of the time
	High availability – drug is easily obtained at any time
	NA – drug is not available at any time
	DK – don’t know if drug is available














Drug Production 
3. Please indicate how cannabis is cultivated in your jurisdiction. (Check ALL that apply.)

Indoors	Outdoors	Hydroponically	Not cultivated	Don’t know


4. Please indicate the level of methamphetamine production in your jurisdiction. (Check only ONE.)

Low production	Moderate production	High production	Not produced	Don’t know

4a. If methamphetamine is produced in your jurisdiction, please indicate the past year change in the level of production.

Increased	Decreased	Remained the same	Not applicable	Don’t know

Diversion/Illicit Use of Controlled Prescription Drugs
5. Indicate the levels of diversion and illicit use for the following types of controlled prescription drugs in your jurisdiction.













Drug Trafficking Activities
6. What are the racial and/or ethnic backgrounds of organizations that are the principal wholesale drug distributors in your jurisdiction (e.g., African American, Caucasian, Dominican, Hispanic, Mexican)? List up to three types for each drug.


Powder Cocaine



Crack Cocaine



Heroin



Methamphetamine



Marijuana



Controlled prescription drugs



Other (specify)





6a. What are the racial and/or ethnic backgrounds of organizations that are the principal retail drug distributors in your jurisdiction (e.g., African American, Caucasian, Dominican, Hispanic, Mexican)? List up to three types for each drug.


Powder Cocaine



Crack Cocaine



Heroin



Methamphetamine



Marijuana



Controlled prescription drugs



Other (specify)




Thank you for your participation! 
























































DEA Headquarters, 8701 Morrissette Drive, Springfield, Virginia 22152 • (202) 353-1112